Loading…
Immunomodulated anterior chemotherapy followed by concurrent chemoradiotherapy in locally advanced tongue cancer: An Institutional experience
Abstract Context: Sequential induction chemotherapy with cisplatin and 5-fluorouracil ( P F) along with interferon-alpha2b and concurrent chemoradiation offers superior loco-regional control for locally advanced carcinoma of oral tongue. Aims: The study was designed to evaluate the beneficial role o...
Saved in:
Published in: | Indian journal of medical and paediatric oncology 2015-01, Vol.36 (1), p.43-48 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c562t-a5aa6eabdf6a55c2377896405a6c52a77cd38e405dd514d8e9c27946fd3e2e3e3 |
---|---|
cites | |
container_end_page | 48 |
container_issue | 1 |
container_start_page | 43 |
container_title | Indian journal of medical and paediatric oncology |
container_volume | 36 |
creator | Chhatui, Bappaditya Roy, Sanjoy Maji, Tapas Lahiri, Debarshi Biswas, Jaydip |
description | Abstract
Context:
Sequential induction chemotherapy with cisplatin and 5-fluorouracil (
P
F) along with interferon-alpha2b and concurrent chemoradiation offers superior loco-regional control for locally advanced carcinoma of oral tongue.
Aims:
The study was designed to evaluate the beneficial role of induction PF chemotherapy and interferon-alpha2b followed by chemoradiation over definitive chemoradiation only for patients with locally advanced carcinoma of oral tongue.
Settings and Design:
Phase II randomized, prospective, open-labeled, single-institutional study.
Methods and Material:
Fifty patients were randomized into 2 arms. Arm A patients were treated with induction chemotherapy with PF regimen for 3 cycles and interferon alpha 2b, 3MU biweekly for 6 such followed by chemoradiation with cisplatin 30 mg/ m 2 / week and external radiotherapy. Arm B patients received chemoradiation only, in the same dose schedule as in Arm A.
Statistical analysis used:
Chi-square test was done to find out the statistical correlation between the two arms. For plotting the disease-free survival (DFS) and overall survival (OS) for the two arms, Kaplan-Meier method was used.
Results:
The loco-regional response rate of patients treated with interferon containing induction chemotherapy followed by concurrent chemoradiation was superior to concurrent chemoradiation only. However the toxicities and treatment interruption were more in patients treated with induction chemotherapy.
Conclusions:
In locally advanced carcinoma of oral tongue, induction chemotherapy with cisplatin and 5-fluorouracil (PF) along with interferon alpha 2b followed by concurrent chemoradiation may produce superior loco-regional control with manageable toxicities that needs to be validated by more randomized trials with adequate number of patients. |
doi_str_mv | 10.4103/0971-5851.151782 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4363850</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A403252966</galeid><sourcerecordid>A403252966</sourcerecordid><originalsourceid>FETCH-LOGICAL-c562t-a5aa6eabdf6a55c2377896405a6c52a77cd38e405dd514d8e9c27946fd3e2e3e3</originalsourceid><addsrcrecordid>eNp1kktv1DAUhSMEoqWwZ4UiISE2M_UjthMWlUYVj5EqsYG15bFvJq4ce3CcwvwI_jNOU4YZBMrCse93jnWvT1G8xGhZYUQvUSPwgtUMLzHDoiaPivN8xBYEk-bx_f9cPiueDcMtQpRhXj8tzgirMWKiOi9-rvt-9KEPZnQqgSmVTxBtiKXuoA-pg6h2-7INzoXvubzZlzp4PcYIPs1MVMYeQOtLF7Rybl8qc6e8zpoU_HaEUk-7-K5c-XLth2TTmGzwypXwY5evhFx9XjxplRvgxcN6UXz98P7L9afFzeeP6-vVzUIzTtJCMaU4qI1puWJMEypE3fAKMcU1I0oIbWgNeW8Mw5WpodFENBVvDQUCFOhFcTX77sZND0bnXqJychdtr-JeBmXlacXbTm7DnawopzVD2eDtg0EM30YYkuztoME55SGMg8ScC1oxIXhGX_-F3oYx5r4nijVCMFLVf6itciCtb0O-V0-mclUhShhp-OS1_AeVPwO9ze8Crc3nJ4I3R4IOlEvdENz95IdTEM2gjmEYIrSHYWAkp6zJKUxyCpOcs5Ylr46HeBD8DlcGLmcgdRZ6OOr7f5a_AEfJ37U</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1659775248</pqid></control><display><type>article</type><title>Immunomodulated anterior chemotherapy followed by concurrent chemoradiotherapy in locally advanced tongue cancer: An Institutional experience</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Chhatui, Bappaditya ; Roy, Sanjoy ; Maji, Tapas ; Lahiri, Debarshi ; Biswas, Jaydip</creator><creatorcontrib>Chhatui, Bappaditya ; Roy, Sanjoy ; Maji, Tapas ; Lahiri, Debarshi ; Biswas, Jaydip ; Devleena</creatorcontrib><description>Abstract
Context:
Sequential induction chemotherapy with cisplatin and 5-fluorouracil (
P
F) along with interferon-alpha2b and concurrent chemoradiation offers superior loco-regional control for locally advanced carcinoma of oral tongue.
Aims:
The study was designed to evaluate the beneficial role of induction PF chemotherapy and interferon-alpha2b followed by chemoradiation over definitive chemoradiation only for patients with locally advanced carcinoma of oral tongue.
Settings and Design:
Phase II randomized, prospective, open-labeled, single-institutional study.
Methods and Material:
Fifty patients were randomized into 2 arms. Arm A patients were treated with induction chemotherapy with PF regimen for 3 cycles and interferon alpha 2b, 3MU biweekly for 6 such followed by chemoradiation with cisplatin 30 mg/ m 2 / week and external radiotherapy. Arm B patients received chemoradiation only, in the same dose schedule as in Arm A.
Statistical analysis used:
Chi-square test was done to find out the statistical correlation between the two arms. For plotting the disease-free survival (DFS) and overall survival (OS) for the two arms, Kaplan-Meier method was used.
Results:
The loco-regional response rate of patients treated with interferon containing induction chemotherapy followed by concurrent chemoradiation was superior to concurrent chemoradiation only. However the toxicities and treatment interruption were more in patients treated with induction chemotherapy.
Conclusions:
In locally advanced carcinoma of oral tongue, induction chemotherapy with cisplatin and 5-fluorouracil (PF) along with interferon alpha 2b followed by concurrent chemoradiation may produce superior loco-regional control with manageable toxicities that needs to be validated by more randomized trials with adequate number of patients.</description><identifier>ISSN: 0971-5851</identifier><identifier>EISSN: 0975-2129</identifier><identifier>DOI: 10.4103/0971-5851.151782</identifier><identifier>PMID: 25810574</identifier><language>eng</language><publisher>A-12, 2nd Floor, Sector 2, Noida-201301 UP, India: Thieme Medical and Scientific Publishers Pvt. Ltd</publisher><subject>Cancer therapies ; Care and treatment ; Chemotherapy ; Cisplatin ; Dosage and administration ; Dysphagia ; Fluorouracil ; Interferon ; Interferon alfa-2b ; Lymphatic system ; Metastasis ; Methods ; Original ; ORIGINAL ARTICLE ; Ovarian cancer ; Patients ; Quality of life ; Radiation therapy ; Radiotherapy ; Response rates ; Surgery ; Tobacco ; Tongue cancer</subject><ispartof>Indian journal of medical and paediatric oncology, 2015-01, Vol.36 (1), p.43-48</ispartof><rights>Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)</rights><rights>COPYRIGHT 2015 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications & Media Pvt Ltd Jan-Mar 2015</rights><rights>Copyright: © Indian Journal of Medical and Paediatric Oncology 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c562t-a5aa6eabdf6a55c2377896405a6c52a77cd38e405dd514d8e9c27946fd3e2e3e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363850/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1659775248?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25751,27922,27923,37010,37011,44588,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25810574$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chhatui, Bappaditya</creatorcontrib><creatorcontrib>Roy, Sanjoy</creatorcontrib><creatorcontrib>Maji, Tapas</creatorcontrib><creatorcontrib>Lahiri, Debarshi</creatorcontrib><creatorcontrib>Biswas, Jaydip</creatorcontrib><creatorcontrib>Devleena</creatorcontrib><title>Immunomodulated anterior chemotherapy followed by concurrent chemoradiotherapy in locally advanced tongue cancer: An Institutional experience</title><title>Indian journal of medical and paediatric oncology</title><addtitle>Indian J Med Paediatr Oncol</addtitle><description>Abstract
Context:
Sequential induction chemotherapy with cisplatin and 5-fluorouracil (
P
F) along with interferon-alpha2b and concurrent chemoradiation offers superior loco-regional control for locally advanced carcinoma of oral tongue.
Aims:
The study was designed to evaluate the beneficial role of induction PF chemotherapy and interferon-alpha2b followed by chemoradiation over definitive chemoradiation only for patients with locally advanced carcinoma of oral tongue.
Settings and Design:
Phase II randomized, prospective, open-labeled, single-institutional study.
Methods and Material:
Fifty patients were randomized into 2 arms. Arm A patients were treated with induction chemotherapy with PF regimen for 3 cycles and interferon alpha 2b, 3MU biweekly for 6 such followed by chemoradiation with cisplatin 30 mg/ m 2 / week and external radiotherapy. Arm B patients received chemoradiation only, in the same dose schedule as in Arm A.
Statistical analysis used:
Chi-square test was done to find out the statistical correlation between the two arms. For plotting the disease-free survival (DFS) and overall survival (OS) for the two arms, Kaplan-Meier method was used.
Results:
The loco-regional response rate of patients treated with interferon containing induction chemotherapy followed by concurrent chemoradiation was superior to concurrent chemoradiation only. However the toxicities and treatment interruption were more in patients treated with induction chemotherapy.
Conclusions:
In locally advanced carcinoma of oral tongue, induction chemotherapy with cisplatin and 5-fluorouracil (PF) along with interferon alpha 2b followed by concurrent chemoradiation may produce superior loco-regional control with manageable toxicities that needs to be validated by more randomized trials with adequate number of patients.</description><subject>Cancer therapies</subject><subject>Care and treatment</subject><subject>Chemotherapy</subject><subject>Cisplatin</subject><subject>Dosage and administration</subject><subject>Dysphagia</subject><subject>Fluorouracil</subject><subject>Interferon</subject><subject>Interferon alfa-2b</subject><subject>Lymphatic system</subject><subject>Metastasis</subject><subject>Methods</subject><subject>Original</subject><subject>ORIGINAL ARTICLE</subject><subject>Ovarian cancer</subject><subject>Patients</subject><subject>Quality of life</subject><subject>Radiation therapy</subject><subject>Radiotherapy</subject><subject>Response rates</subject><subject>Surgery</subject><subject>Tobacco</subject><subject>Tongue cancer</subject><issn>0971-5851</issn><issn>0975-2129</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>0U6</sourceid><sourceid>PIMPY</sourceid><recordid>eNp1kktv1DAUhSMEoqWwZ4UiISE2M_UjthMWlUYVj5EqsYG15bFvJq4ce3CcwvwI_jNOU4YZBMrCse93jnWvT1G8xGhZYUQvUSPwgtUMLzHDoiaPivN8xBYEk-bx_f9cPiueDcMtQpRhXj8tzgirMWKiOi9-rvt-9KEPZnQqgSmVTxBtiKXuoA-pg6h2-7INzoXvubzZlzp4PcYIPs1MVMYeQOtLF7Rybl8qc6e8zpoU_HaEUk-7-K5c-XLth2TTmGzwypXwY5evhFx9XjxplRvgxcN6UXz98P7L9afFzeeP6-vVzUIzTtJCMaU4qI1puWJMEypE3fAKMcU1I0oIbWgNeW8Mw5WpodFENBVvDQUCFOhFcTX77sZND0bnXqJychdtr-JeBmXlacXbTm7DnawopzVD2eDtg0EM30YYkuztoME55SGMg8ScC1oxIXhGX_-F3oYx5r4nijVCMFLVf6itciCtb0O-V0-mclUhShhp-OS1_AeVPwO9ze8Crc3nJ4I3R4IOlEvdENz95IdTEM2gjmEYIrSHYWAkp6zJKUxyCpOcs5Ylr46HeBD8DlcGLmcgdRZ6OOr7f5a_AEfJ37U</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Chhatui, Bappaditya</creator><creator>Roy, Sanjoy</creator><creator>Maji, Tapas</creator><creator>Lahiri, Debarshi</creator><creator>Biswas, Jaydip</creator><general>Thieme Medical and Scientific Publishers Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications & Media Pvt. Ltd</general><general>Medknow Publications & Media Pvt Ltd</general><scope>0U6</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PADUT</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150101</creationdate><title>Immunomodulated anterior chemotherapy followed by concurrent chemoradiotherapy in locally advanced tongue cancer: An Institutional experience</title><author>Chhatui, Bappaditya ; Roy, Sanjoy ; Maji, Tapas ; Lahiri, Debarshi ; Biswas, Jaydip</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c562t-a5aa6eabdf6a55c2377896405a6c52a77cd38e405dd514d8e9c27946fd3e2e3e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Cancer therapies</topic><topic>Care and treatment</topic><topic>Chemotherapy</topic><topic>Cisplatin</topic><topic>Dosage and administration</topic><topic>Dysphagia</topic><topic>Fluorouracil</topic><topic>Interferon</topic><topic>Interferon alfa-2b</topic><topic>Lymphatic system</topic><topic>Metastasis</topic><topic>Methods</topic><topic>Original</topic><topic>ORIGINAL ARTICLE</topic><topic>Ovarian cancer</topic><topic>Patients</topic><topic>Quality of life</topic><topic>Radiation therapy</topic><topic>Radiotherapy</topic><topic>Response rates</topic><topic>Surgery</topic><topic>Tobacco</topic><topic>Tongue cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chhatui, Bappaditya</creatorcontrib><creatorcontrib>Roy, Sanjoy</creatorcontrib><creatorcontrib>Maji, Tapas</creatorcontrib><creatorcontrib>Lahiri, Debarshi</creatorcontrib><creatorcontrib>Biswas, Jaydip</creatorcontrib><creatorcontrib>Devleena</creatorcontrib><collection>Thieme Connect Journals Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Research Library China</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Indian journal of medical and paediatric oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chhatui, Bappaditya</au><au>Roy, Sanjoy</au><au>Maji, Tapas</au><au>Lahiri, Debarshi</au><au>Biswas, Jaydip</au><aucorp>Devleena</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunomodulated anterior chemotherapy followed by concurrent chemoradiotherapy in locally advanced tongue cancer: An Institutional experience</atitle><jtitle>Indian journal of medical and paediatric oncology</jtitle><addtitle>Indian J Med Paediatr Oncol</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>36</volume><issue>1</issue><spage>43</spage><epage>48</epage><pages>43-48</pages><issn>0971-5851</issn><eissn>0975-2129</eissn><abstract>Abstract
Context:
Sequential induction chemotherapy with cisplatin and 5-fluorouracil (
P
F) along with interferon-alpha2b and concurrent chemoradiation offers superior loco-regional control for locally advanced carcinoma of oral tongue.
Aims:
The study was designed to evaluate the beneficial role of induction PF chemotherapy and interferon-alpha2b followed by chemoradiation over definitive chemoradiation only for patients with locally advanced carcinoma of oral tongue.
Settings and Design:
Phase II randomized, prospective, open-labeled, single-institutional study.
Methods and Material:
Fifty patients were randomized into 2 arms. Arm A patients were treated with induction chemotherapy with PF regimen for 3 cycles and interferon alpha 2b, 3MU biweekly for 6 such followed by chemoradiation with cisplatin 30 mg/ m 2 / week and external radiotherapy. Arm B patients received chemoradiation only, in the same dose schedule as in Arm A.
Statistical analysis used:
Chi-square test was done to find out the statistical correlation between the two arms. For plotting the disease-free survival (DFS) and overall survival (OS) for the two arms, Kaplan-Meier method was used.
Results:
The loco-regional response rate of patients treated with interferon containing induction chemotherapy followed by concurrent chemoradiation was superior to concurrent chemoradiation only. However the toxicities and treatment interruption were more in patients treated with induction chemotherapy.
Conclusions:
In locally advanced carcinoma of oral tongue, induction chemotherapy with cisplatin and 5-fluorouracil (PF) along with interferon alpha 2b followed by concurrent chemoradiation may produce superior loco-regional control with manageable toxicities that needs to be validated by more randomized trials with adequate number of patients.</abstract><cop>A-12, 2nd Floor, Sector 2, Noida-201301 UP, India</cop><pub>Thieme Medical and Scientific Publishers Pvt. Ltd</pub><pmid>25810574</pmid><doi>10.4103/0971-5851.151782</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0971-5851 |
ispartof | Indian journal of medical and paediatric oncology, 2015-01, Vol.36 (1), p.43-48 |
issn | 0971-5851 0975-2129 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4363850 |
source | Publicly Available Content Database; PubMed Central |
subjects | Cancer therapies Care and treatment Chemotherapy Cisplatin Dosage and administration Dysphagia Fluorouracil Interferon Interferon alfa-2b Lymphatic system Metastasis Methods Original ORIGINAL ARTICLE Ovarian cancer Patients Quality of life Radiation therapy Radiotherapy Response rates Surgery Tobacco Tongue cancer |
title | Immunomodulated anterior chemotherapy followed by concurrent chemoradiotherapy in locally advanced tongue cancer: An Institutional experience |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T10%3A24%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunomodulated%20anterior%20chemotherapy%20followed%20by%20concurrent%20chemoradiotherapy%20in%20locally%20advanced%20tongue%20cancer:%20An%20Institutional%20experience&rft.jtitle=Indian%20journal%20of%20medical%20and%20paediatric%20oncology&rft.au=Chhatui,%20Bappaditya&rft.aucorp=Devleena&rft.date=2015-01-01&rft.volume=36&rft.issue=1&rft.spage=43&rft.epage=48&rft.pages=43-48&rft.issn=0971-5851&rft.eissn=0975-2129&rft_id=info:doi/10.4103/0971-5851.151782&rft_dat=%3Cgale_pubme%3EA403252966%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c562t-a5aa6eabdf6a55c2377896405a6c52a77cd38e405dd514d8e9c27946fd3e2e3e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1659775248&rft_id=info:pmid/25810574&rft_galeid=A403252966&rfr_iscdi=true |